Not a good buy right now for an impatient buyer: the broader trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum remains negative (MACD histogram below 0 and expanding).
The stock is deeply oversold (RSI_6 ~14), so a short-term bounce is possible, but there is no Intellectia buy signal to prioritize today.
With earnings scheduled pre-market on 2026-02-05, price direction is likely to be decided by the report; without a clear technical reversal yet, the risk/reward for buying immediately is not attractive.
Best stance now: HOLD and only turn constructive if price reclaims key levels (notably the 14.73 pivot) with improving momentum.
Technical Analysis
Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), implying the dominant trend is still down.
Momentum: MACD histogram at -0.256 and negatively expanding signals weakening momentum and no confirmed reversal yet.
Mean reversion setup: RSI_6 at 14.161 indicates extreme oversold conditions; this often precedes dead-cat bounces, but it’s not a standalone buy trigger without confirmation.
Key levels:
Support: S1 13.305 (near-term), then S2 12.425.
Resistance: Pivot 14.73 (first “trend-change” checkpoint), then R1 16.155.
Near-term pattern odds (similar-candlestick analog): modest expected move next day/week and slightly negative 1-month bias, not supportive of an aggressive immediate buy.
Positioning/lean: Put-call OI ratio at 0.21 is strongly call-heavy, suggesting bullish positioning vs puts.
Activity: Today’s options volume (183) is elevated vs the 30-day average (53.2%), indicating increased attention.
Volatility: IV (30d) 68.84 vs historical vol 81.45; IV percentile 14.4 and IV rank ~11 imply options are relatively “cheap” versus recent history.
Interpretation: Options sentiment is moderately bullish (call-skewed) and could support a rebound attempt, but it has not yet translated into a technical trend reversal.
Technical Summary
Sell
7
Buy
4
Positive Catalysts
creates a strong mean-reversion tailwind for a short-term bounce if buyers step in.
Neutral/Negative Catalysts
Clear bearish trend and weakening momentum (MA stack bearish; MACD histogram negative and expanding) increases the odds rallies fade.
Key resistance overhead at 14.73 pivot; failure to reclaim it keeps the chart in “sell-the-rip” mode.
Gross margin declined YoY in the latest quarter, which can weigh on quality of earnings if it persists.
No supportive recent news flow; the next major directional trigger is earnings, which can cut either way.
Gross margin: 60.05%, -3.77% YoY (margin compression is the main blemish; watch if it’s temporary or structural).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data was provided in the dataset, so there is no observable recent trend in Street upgrades/downgrades.
Wall Street pros (based on fundamentals provided): accelerating revenue and earnings growth.
Wall Street cons (based on financial + tape): gross margin deterioration and a technically bearish chart trend with negative momentum.
Wall Street analysts forecast BYRN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BYRN is 43 USD with a low forecast of 40 USD and a high forecast of 46 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast BYRN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BYRN is 43 USD with a low forecast of 40 USD and a high forecast of 46 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.160
Low
40
Averages
43
High
46
Current: 13.160
Low
40
Averages
43
High
46
Roth Capital
Buy
maintain
$33 -> $35
AI Analysis
2025-07-24
Reason
Roth Capital
Price Target
$33 -> $35
AI Analysis
2025-07-24
maintain
Buy
Reason
Roth Capital raised the firm's price target on Byrna Technologies (BYRN) to $35 from $33 and keeps a Buy rating on the shares. Byrna shared several positive key metrics, including successful promotional events around July 4th and Prime Day at Amazon (AMZN), which should enable sustained strong growth in the company's direct to consumer channel, while also highlighting robust Wholesale door growth, the analyst tells investors in a research note.
Craig-Hallum
Jeremy Hamblin
initiated
$39
2025-07-16
Reason
Craig-Hallum
Jeremy Hamblin
Price Target
$39
2025-07-16
initiated
Reason
Craig-Hallum analyst Jeremy Hamblin initiated coverage of Byrna Technologies with a Buy rating and $39 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BYRN
